These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34588988)

  • 1. Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis.
    Kong F; Wang C; Li X; Jia Y
    Front Pharmacol; 2021; 12():739843. PubMed ID: 34588988
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs.
    Li D; Li W; Xu L; Che Y; Cheng C
    Medicine (Baltimore); 2022 Dec; 101(50):e32169. PubMed ID: 36550917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
    J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
    Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
    Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer.
    Xiao N; He H; Wang J; Zhang L; Chow B; Feng F; Xu Y; Huang J; Zhou X; Dong R
    J Evid Based Integr Med; 2021; 26():2515690X211010733. PubMed ID: 33926244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Kanglaite injection combined with radiochemotherapy in the treatment of advanced pancreatic cancer: A PRISMA-compliant meta-analysis.
    Liu J; Yu L; Ding W
    Medicine (Baltimore); 2019 Aug; 98(32):e16656. PubMed ID: 31393364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis.
    Liu X; Xu F; Wang G; Diao X; Li Y
    Curr Ther Res Clin Exp; 2008 Oct; 69(5):381-411. PubMed ID: 24692815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis on effectiveness and safety of traditional Chinese medicine combined with first-generation EGFR-TKI in treating advanced non-small cell lung cancer].
    He W; Cheng M
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2591-2598. PubMed ID: 28840704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the clinical effect of Kanglaite injection-assisted gemcitabine plus cisplatin regimen on non-small cell lung cancer.
    Lv P; Liu M
    Am J Transl Res; 2023; 15(5):2999-3012. PubMed ID: 37303638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Stage III/IV Non-Small Cell Lung Cancer: A Meta-analysis and Systematic Review of 35 Randomized Controlled Trials.
    Li H; Ji Y; Zhang S; Gao Z; Hu C; Jiang R; Chen M; Li G; Zhang X
    J Cancer; 2019; 10(21):5283-5298. PubMed ID: 31602279
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs.
    Li J; Li HZ; Zhu GH; Gao RK; Zhang Y; Hou W; Li J
    Ann Palliat Med; 2020 Jul; 9(4):1518-1535. PubMed ID: 32692199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of kanglaite injection in combination with gefitinib versus gefitinib alone in patients with nonsmall cell lung cancer: A meta-analysis.
    Hailang H; Jiping Z; Ailing C; Xianmei Z
    J Cancer Res Ther; 2020; 16(4):745-751. PubMed ID: 32930113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis.
    Li S; Xu S; Li L; Xue Z; He L
    Front Neurol; 2024; 15():1362061. PubMed ID: 38737351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
    Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer.
    Zhai H; Zhong W; Yang X; Wu YL
    Transl Lung Cancer Res; 2015 Feb; 4(1):82-93. PubMed ID: 25806348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).
    Zhang Z; Luo F; Zhang Y; Ma Y; Hong S; Yang Y; Fang W; Huang Y; Zhang L; Zhao H
    Cancer Commun (Lond); 2019 Nov; 39(1):69. PubMed ID: 31699150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese Herbal Medicine Combined With First-Generation EGFR-TKIs in Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Sensitizing Mutation: A Systematic Review and Meta-Analysis.
    Lu Y; Sun C; Jiao L; Liu Y; Gong Y; Xu L
    Front Pharmacol; 2021; 12():698371. PubMed ID: 34512332
    [No Abstract]   [Full Text] [Related]  

  • 20. Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma.
    Liu X; Yang Q; Xi Y; Yu K; Wang W; Zhao X; Kou X
    J Cancer Res Ther; 2014 Aug; 10 Suppl 1():46-51. PubMed ID: 25207891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.